Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
divvyDOSE is a U.S. full-service digital and mail-order pharmacy focused on improving medication adherence for patients with chronic conditions and complex medication regimens. The company organizes prescription drugs, over-the-counter medications, and supplements into personalized pill packs labeled by date and time, and ships them directly to patients. It also provides pharmacy support and works with prescribers and caregivers to simplify ongoing medication management. Founded by physician Arvind Movva, divvyDOSE was acquired by UnitedHealth Group in 2020 and now operates as part of Optum. The business is commercial and service-oriented rather than a drug developer, so it does not have a traditional therapeutic R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on divvyDOSE.